Company Filing History:
1 out of 223 
1 out of 238 
Years Active: 2022
Title: Joseph McInnes: Innovator in Tauopathy Treatment
Introduction
Joseph McInnes is a notable inventor based in Leuven, Belgium. He has made significant contributions to the field of medical research, particularly in the treatment of tauopathies. His innovative work focuses on identifying new therapeutic targets to combat these complex neurological disorders.
Latest Patents
Joseph McInnes holds a patent titled "Targeting synaptogyrin-3 in tauopathy treatment." This invention relates to the identification of synaptogyrin-3 as a target for treating or inhibiting the progression of tauopathies or their symptoms. Specifically, the patent envisions the use of synaptogyrin-3 inhibitors as a medicament for these conditions. Furthermore, it outlines methods for identifying or screening for inhibitors of synaptogyrin-3.
Career Highlights
Throughout his career, Joseph McInnes has worked with various esteemed organizations. He has been associated with Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Joseph McInnes has collaborated with notable colleagues, including Patrik Verstreken and Lujia Zhou. These partnerships have enriched his research endeavors and fostered innovation in the field of tauopathy treatment.
Conclusion
Joseph McInnes is a pioneering inventor whose work on targeting synaptogyrin-3 represents a significant advancement in the treatment of tauopathies. His contributions to medical research continue to inspire and pave the way for future innovations.